Literature DB >> 21432264

Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.

Chikako Kiyohara1, Taro Shirakawa, Julian M Hopkin.   

Abstract

Chronic inhalation of cigarette smoke is a major risk factor for the development of lung cancer. It has been suggested that genetic susceptibility may contribute to the risk, because only a small portion of smokers develops the disease. Several polymorphisms that involve the metabolic activation or detoxification of carcinogens derived from cigarette smoke have been found to be associated with lung cancer risk. Many studies have focused on the relation between the distribution of polymorphic variants of different forms of the metabolic enzymes and lung cancer susceptibility. In this respect two groups of genetic polymorphisms of enzymes involved in xenobiotic metabolism, cytochrome P450 (CYP) and glutathione S-transferases (GSTs), have been discussed.CYP multigene superfamily consists of 10 subfamilies (CYP1-CYP10). A positive association between development of lung cancer and the mutant homozygous genotype ofCYP1A1 gene has been reported in several Japanese populations but such an association has not been observed in either Caucasians or African-Americans. The relation betweenCYP2D6 and lung cancer remains conflicting and inconclusive. Several polymorphisms have been identified at theCYP2E1 locus. No definitive link between the polymorphisms ofCYP2E1 and the risk of lung cancer has, however, been identified. The role of otherCYP2 isoforms in lung carcinogenesis has not been sufficiently investigated.GSTs form a superfamily of genes consisting of five distinct families, namedGSTA, GSTM, GSTP, GSTT andGSTS. The role ofGSTM, GSTT1 orGSTP1 polymorphism in modifying the lung cancer risk may be more limited than has been so far anticipated.Although some genetic polymorphisms discussed here have not shown significant increases/decreases in risk, individuals with differing genotypes may have different susceptibilities to lung cancer. Hopefully, in future studies it will be possible to screen for lung cancer using specific biomarkers.

Entities:  

Keywords:  drug-metabolizing enzymes; ethnic difference; genetic polymorphism; lung cancer; molecular epidemiology

Year:  2002        PMID: 21432264      PMCID: PMC2723399          DOI: 10.1007/BF02897330

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  134 in total

1.  CYP2D6 genotyping and the association with lung cancer susceptibility.

Authors:  C R Wolf; C A Smith; T Bishop; D Forman; A C Gough; N K Spurr
Journal:  Pharmacogenetics       Date:  1994-04

2.  The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population.

Authors:  C Kiyohara; Y Nakanishi; S Inutsuka; K Takayama; N Hara; A Motohiro; K Tanaka; S Kono; T Hirohata
Journal:  Pharmacogenetics       Date:  1998-08

3.  Genetic polymorphism of CYP2D6 and lung cancer risk.

Authors:  G L Shaw; R T Falk; J N Frame; B Weiffenbach; J C Nesbitt; H I Pass; N E Caporaso; D T Moir; M A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-03       Impact factor: 4.254

4.  Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study.

Authors:  J Seidegård; R W Pero; M M Markowitz; G Roush; D G Miller; E J Beattie
Journal:  Carcinogenesis       Date:  1990-01       Impact factor: 4.944

5.  Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice.

Authors:  L W Wattenberg
Journal:  Carcinogenesis       Date:  1987-12       Impact factor: 4.944

6.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.

Authors:  K Nakachi; K Imai; S Hayashi; K Kawajiri
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

7.  Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls.

Authors:  V Dolzan; Z Rudolf; K Breskvar
Journal:  Carcinogenesis       Date:  1995-11       Impact factor: 4.944

8.  Cytochrome P-450 lA1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil.

Authors:  H Sugimura; I Suzuki; G S Hamada; T Iwase; T Takahashi; K Nagura; H Iwata; S Watanabe; I Kino; S Tsugane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-03       Impact factor: 4.254

9.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer.

Authors:  S T Saarikoski; A Voho; M Reinikainen; S Anttila; A Karjalainen; C Malaveille; H Vainio; K Husgafvel-Pursiainen; A Hirvonen
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

10.  The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer.

Authors:  B Ketterer; J M Harris; G Talaska; D J Meyer; S E Pemble; J B Taylor; N P Lang; F F Kadlubar
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more
  9 in total

1.  Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.

Authors:  R C Sobti; S Sharma; A Joshi; S K Jindal; A Janmeja
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

2.  The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population.

Authors:  Yanan Zhang; Chibo Liu
Journal:  Tumour Biol       Date:  2012-10-23

3.  Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers.

Authors:  Kyriaki Pliarchopoulou; Gerasimos Voutsinas; George Papaxoinis; Katherine Florou; Maria Skondra; Konstantina Kostaki; Paraskevi Roussou; Konstantinos Syrigos; Dimitrios Pectasides
Journal:  Oncol Lett       Date:  2012-03-30       Impact factor: 2.967

4.  Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review.

Authors:  Michele L Cote; Wei Chen; Daryn W Smith; Simone Benhamou; Christine Bouchardy; Dorota Butkiewicz; Kwun M Fong; Manuel Gené; Ari Hirvonen; Chikako Kiyohara; Jill E Larsen; Pinpin Lin; Ole Raaschou-Nielsen; Andrew C Povey; Edyta Reszka; Angela Risch; Joachim Schneider; Ann G Schwartz; Mette Sorensen; Jordi To-Figueras; Shinkan Tokudome; Yuepu Pu; Ping Yang; Angela S Wenzlaff; Harriet Wikman; Emanuela Taioli
Journal:  Am J Epidemiol       Date:  2009-02-24       Impact factor: 4.897

Review 5.  Polycyclic aromatic hydrocarbons and cytochrome P450 in HIV pathogenesis.

Authors:  P S S Rao; Santosh Kumar
Journal:  Front Microbiol       Date:  2015-06-02       Impact factor: 5.640

Review 6.  GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis.

Authors:  Fengying Zhang; Xijiang Wu; Jinming Niu; Xiufeng Kang; Liya Cheng; Yanchun Lv; Meimei Wu
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

7.  Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility.

Authors:  Meng Li; Anqi Li; Ruiqing He; Wenhui Dang; Xinyu Liu; Tian Yang; Puyu Shi; Xiang Bu; Dan Gao; Ning Zhang; Shuli Du; Tianbo Jin; Mingwei Chen
Journal:  Cancer Med       Date:  2019-07-01       Impact factor: 4.452

8.  The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People

Authors:  Gholamreza Shahsavari; Ali Amiri; Masoud Shamaei; Glavizh Adibhesami; Amirnader Emami Razavi; Mehdi Birjandi; Mihan Pourabdollah
Journal:  Asian Pac J Cancer Prev       Date:  2019-05-25

9.  MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis.

Authors:  Hesen Peng; Junjie Ma; Yun Bai; Jianwei Lu; Tianwei Yu
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.